Vident Investment Advisory, LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 248 filers reported holding NEKTAR THERAPEUTICS in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
Vident Investment Advisory, LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q1 2023$34,109
-68.5%
48,709
+1.8%
0.00%
-75.0%
Q4 2022$108,166
-84.1%
47,861
-77.7%
0.00%
-81.8%
Q3 2022$679,000
-22.4%
214,322
-7.0%
0.02%
-15.4%
Q2 2022$875,000
+67.9%
230,411
+138.4%
0.03%
+85.7%
Q1 2022$521,000
-54.2%
96,652
+14.9%
0.01%
-53.3%
Q4 2021$1,137,000
-25.3%
84,152
-0.7%
0.03%
-34.8%
Q3 2021$1,522,000
-11.5%
84,777
-15.4%
0.05%
-11.5%
Q2 2021$1,719,000
-14.7%
100,203
-0.5%
0.05%
-23.5%
Q1 2021$2,015,000
+18.5%
100,706
+0.6%
0.07%
-1.4%
Q4 2020$1,701,000
+62.0%
100,074
+58.2%
0.07%
+32.7%
Q3 2020$1,050,000
-37.2%
63,261
-12.4%
0.05%
-40.9%
Q2 2020$1,673,000
+32.8%
72,240
+2.3%
0.09%
+7.3%
Q1 2020$1,260,000
-53.2%
70,622
-43.4%
0.08%
-50.9%
Q4 2019$2,695,000
+256.5%
124,853
+200.7%
0.17%
+153.0%
Q3 2019$756,000
-62.6%
41,519
-26.9%
0.07%
-59.5%
Q2 2019$2,020,000
-45.6%
56,778
-48.6%
0.16%
-18.5%
Q1 2019$3,714,000
+102.5%
110,551
+98.1%
0.20%
+94.2%
Q4 2018$1,834,000
-46.5%
55,811
-0.7%
0.10%
-23.1%
Q3 2018$3,428,000
+32.5%
56,228
+6.1%
0.13%
+31.4%
Q2 2018$2,588,000
-18.8%
52,994
+49.9%
0.10%
-21.5%
Q1 2018$3,188,000
+104.2%
35,354
+65.7%
0.13%
+85.7%
Q4 2017$1,561,00021,3390.07%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2020
NameSharesValueWeighting ↓
Rhenman & Partners Asset Management AB 508,000$6,132,0001.80%
Bodri Capital Management, LLC 250,000$3,018,0001.46%
Granahan Investment Management 3,442,980$41,557,0001.28%
TIRSCHWELL & LOEWY INC 603,441$7,284,0001.22%
NEA Management Company, LLC 1,825,600$22,035,0001.12%
Cormorant Asset Management, LP 450,000$5,432,0001.12%
HARVEY CAPITAL MANAGEMENT INC 221,750$2,676,0001.05%
Cheyne Capital Management (UK) LLP 229,577$2,772,0000.99%
Artal Group S.A. 1,650,000$19,916,0000.73%
FIC CAPITAL INC 147,293$1,778,0000.71%
View complete list of NEKTAR THERAPEUTICS shareholders